ALK inhibitors bind to the ATP-binding pocket of the intracellular tyrosine kinase domain, and regulate their downstream signals such as the RAS, PI3K-AKT, JAK/STAT signaling cascades which are involved in tumor progression; attenuation of these cascades produces an antitumor effect [8,20,27]. Here, ALK is linked to neoplasm.